Evoke Pharma, Inc.
(NASDAQ : EVOK)

( )
EVOK PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.01%170.190.7%$968.89m
PFEPfizer Inc. 0.42%49.780.9%$831.56m
ABBVAbbVie, Inc. -0.06%140.261.9%$828.10m
MRKMerck & Co., Inc. 1.18%89.530.7%$782.75m
LLYEli Lilly & Co. 0.15%302.941.1%$765.74m
BMYBristol-Myers Squibb Co. 1.59%74.971.0%$667.48m
SIGASIGA Technologies, Inc. 2.70%22.790.0%$421.60m
AZNAstraZeneca Plc 1.18%65.891.0%$366.83m
ALNYAlnylam Pharmaceuticals, Inc. -3.19%223.378.1%$270.23m
GBTGlobal Blood Therapeutics, Inc. -0.02%66.595.6%$260.89m
GSKGSK Plc -0.79%39.990.3%$212.92m
HZNPHorizon Therapeutics Plc -3.63%67.125.4%$204.87m
NVSNovartis AG 1.39%87.130.2%$176.66m
CCXIChemoCentryx, Inc. -0.20%50.792.9%$168.36m
SGENSeagen Inc. -1.53%175.605.7%$163.66m

Company Profile

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.